Educo Bangladesh has launched a COVID-19 emergency response to help ensure vulnerable children and their families survive the devastating impact of the coronavirus pandemic, providing cash support, food packs, and health hygiene support to 7,684 struggling families.

As in many parts of the world, the number of confirmed COVID-19 cases across Bangladesh has reached more than 55,000, including 746 deaths (IEDCR, as of 3 June 2020). Educo also expressed concerns over the impact of low-income families being unable to earn for their children and themselves during the lockdown.

Country Director of Educo Bangladesh Abdul Hamid says:

“We know that the ordeal is far from over even when the national lockdown has been eased, especially that many informal and subsistence wage earners have lost their jobs. We know from experience that loss of income for many vulnerable families will have lasting impact on the well-being and health of children. They are also most affected now that schools have been closed and many children do not have access to learning alternatives.”

Educo’s humanitarian response has provided 5,414 vulnerable families with 1,000 taka each, including families of children studying in Educo schools living in Dhaka’s slums and Narayangonj districts; and children and families supported by the organization’s anti-child labor project ODHIKAR (Options for Dignity of Human Being by Influencing Key Actors to Reform). In Rajshahi and Chapai Nawabgonj districts, Educo distributed life-saving food packs containing 10 kg rice, 2kg dal (pulses), 1 litre oil, 3 kg potatoes, and 1kg salt to 1,000 plain land Adibashi families, many of whom are vulnerable and marginalized.

To support the underprivileged children living in different brothels of Rajbari and Faridpur, Educo provided 1,270 food and hygiene kit packages (Rice 5 kg, Dal 2kg, oil 1litre, Potato 3 kg, Salt 1 kg, Detergent 01 KG, 01 Soap, 01 mask) and 280 child-food support packages containing 1kg sugar, 500g semolina, 250g milk and biscuits. The organization has implemented the response with the support of its three partners, namely Echo-Social Development Organization (ESDO), Sachetan, and Shapla Mohila Shangstha (SMS).

Educo appreciates the efforts of Bangladesh Government and stands in solidarity to ensure the well-being and protection of the most vulnerable children under these challenging circumstances. In future, Educo will continue its humanitarian programmes for the greater well-being of children and their families. Educo expects for a safe and secured world where every child gets the opportunity to realize their potentials

COVID-19 RESPONSE: PHASE 1

COVID-19 RESPONSE: PHASE 2

WHAT YOU NEED TO KNOW ABOUT COVID-19

A novel coronavirus is a new coronavirus that has not been previously identified. The virus causing coronavirus disease 2019 (COVID-19) is not the same as the coronaviruses that commonly circulate among humans and cause mild illness, like the common cold.

Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. There are many types of human coronaviruses, including some that commonly cause mild upper-respiratory tract illnesses. COVID-19 is a new disease, caused by a novel (or new) coronavirus that has not previously been seen in humans. Current symptoms reported for patients with COVID-19 have included mild to severe respiratory illness with cough, and shortness of breath or difficulty breathing; or at least two of these symptoms: fever, chills, repeated shaking with chills, muscle pain, headache, sore throat, or a new loss of taste or smell. You may have other symptoms.

The best way to prevent illness is to avoid being exposed to the virus. CDC recommends everyday preventive actions to help prevent the spread of respiratory diseases.

The virus is transmitted through direct contact with respiratory droplets of an infected person (generated through coughing and sneezing), and touching surfaces contaminated with the virus. The virus may survive on surfaces for several hours, but simple disinfectants can kill it

It is recommended wearing cloth face coverings in public when other social distancing measures are difficult to maintain (e.g., grocery stores and pharmacies) especially in areas of significant community-based transmission of the coronavirus. The purpose of wearing cloth face coverings in public is to slow the spread of the virus and help people who may have the virus and do not know it from transmitting it to others.

People with COVID-19 should receive supportive care to help relieve symptoms. People with mild symptoms are able to recover at home. If you experience a medical emergency such as trouble breathing, call 333/16263 and let the operator know you may have COVID-19. For severe illness, treatment should include care to support vital organ functions.

Currently there are no globally approved drugs specifically for the treatment of COVID-19. Researchers are studying new drugs, and drugs that are already approved for other health conditions, as possible treatments for COVID-19.

No. Always follow the instructions on household cleaners. Disinfectant sprays or wipes are intended for use on hard, non-porous surfaces. Disinfectant sprays or wipes are not intended for use on humans or animals. Do not use disinfectant sprays or wipes on your skin because they may cause skin and eye irritation. Do not inject, inhale, or ingest disinfectant sprays or household cleaners; doing so is dangerous and may cause serious harm or death. If ingested, call poison control or a medical professional immediately.

Convalescent plasma is the liquid part of blood that is collected from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-CoV-2. COVID-19 patients develop antibodies in the blood against the virus. Antibodies are proteins that might help fight the infection. Convalescent plasma is being investigated for the treatment of COVID-19 because there is no approved treatment for this disease and there is some information that suggests it might help some patients recover from COVID-19. Further investigation is still necessary to determine if convalescent plasma might shorten the duration of illness, reduce morbidity, or prevent death associated with COVID-19.

COVID-19 convalescent plasma must only be collected from recovered individuals if they are eligible to donate blood. Individuals must have had a prior diagnosis of COVID-19 documented by a laboratory test and meet other laboratory criteria. Individuals must have fully recovered from COVID-19, with complete resolution of symptoms for at least 14 days before donation of convalescent plasma.

There are steps you can take to help protect yourself, grocery store workers and other shoppers, such as wearing a face covering, practicing social distancing, and using wipes on the handles of the shopping cart or basket.

Currently there is no evidence of food, food containers, or food packaging being associated with transmission of COVID-19. Like other viruses, it is possible that the virus that causes COVID-19 can survive on surfaces or objects. If you are concerned about contamination of food or food packaging, wash your hands after handling food packaging, after removing food from the packaging, before you prepare food for eating and before you eat.